At Prima ENT Hospitals, we provide comprehensive medical and surgical care for patients diagnosed with sinonasal mucormycosis, a serious fungal infection primarily affecting the sinus and nasal passages. Our expert team of ENT specialists and surgeons use advanced diagnostic tools and treatment methods to manage and treat this life-threatening condition.
Q1: What is sinonasal mucormycosis? Sinonasal mucormycosis is a rare but serious fungal infection that affects the nasal passages and sinuses, primarily in immunocompromised individuals. It is caused by fungi in the order Mucorales.
Q2: What are the symptoms of sinonasal mucormycosis? Symptoms may include nasal congestion, swelling around the eyes or cheeks, black lesions on nasal bridge or upper inside of the mouth, fever, headache, and acute sinusitis symptoms that do not respond to standard treatment.
Q3: Who is at risk of developing sinonasal mucormycosis? Individuals with weakened immune systems, such as those with diabetes, cancer, organ transplant, or those receiving corticosteroids, are at higher risk.
Q4: How is sinonasal mucormycosis treated at Prima ENT Hospitals? Treatment typically involves a combination of antifungal medication and surgical debridement. The specific approach depends on the extent of the disease and the patient's overall health.
Q5: What is the success rate of treatment for sinonasal mucormycosis? The success rate can vary widely depending on the promptness of diagnosis and treatment initiation. Early medical intervention significantly improves outcomes.
Q6: Can sinonasal mucormycosis recur? Yes, it can recur, especially if the underlying conditions that led to the initial infection are not adequately managed. Continuous follow-up is essential to monitor for any signs of recurrence.